Functional composition in eye cream, eye cream and preparation method of eye cream
A composition and eye cream technology, which can be applied in the directions of skin care preparations, medical preparations containing active ingredients, pharmaceutical formulas, etc., and can solve the problems of poor eye cream effect and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0054] The present embodiment provides a kind of eye cream for staying up late, comprising the following components by weight percentage:
[0055] Phase A (oil phase):
[0056] 1. Polyglycerol-10 stearate 0.5%; 2. Capryl polymethicone 1.0%; 3. Polydimethylsiloxane 1.0%; 4. Polymethylsilsesquioxane 0.5% 5. Babassu seed oil 1.0%; 6. Phytosterol oleate 0.4%; 7. Tocopheryl acetate 0.5%;
[0057] Phase B (including part of the water phase):
[0058] 8. Ultrapure water 49.25%; 9. Glycerin 8.0%; 10. 1,3-Propanediol 3.0%; 11. Hydrogenated lecithin 0.5%; 12. EMT-15 (hydroxyethyl acrylate / acryloyl dimethyl taurine Sodium Acetate Copolymer) 0.5%; 13. Carbomer 0.4%; 14. GT-730 (PEG-240 / HDI Copolymer Bis-Decyl Tetradeceth-20 Ether, Butylene Glycol) 1.5%; 15 , Sodium hyaluronate 0.1%; 16. Polyglutamic acid 0.5%;
[0059] Phase C: 17. Triethanolamine 0.3%;
[0060] Phase D (Performance Composition, (Dimethicone / Vinyl Dimethicone Crosspolymer, Water, C12-14 Pareth-12), and Anti-Sensitivi...
Embodiment 2
[0072] The present embodiment provides a kind of eye cream for staying up late, comprising the following components by weight percentage:
[0073] Phase A (oil phase):
[0074] 1. Polyglycerol-10 stearate 0.5%; 2. Capryl polymethicone 1.0%; 3. Polydimethylsiloxane 1.0%; 4. Polymethylsilsesquioxane 0.5% 5. Babassu seed oil 1.0%; 6. Phytosterol oleate 0.4%; 7. Tocopheryl acetate 0.5%;
[0075] Phase B (including part of the water phase):
[0076] 8. Ultrapure water 50.75%; 9. Glycerin 8.0%; 10. 1,3-Propanediol 3.0%; 11. Hydrogenated lecithin 0.5%; 12. EMT-15 (hydroxyethyl acrylate / acryloyl dimethyl taurine Sodium Acetate Copolymer) 0.5%; 13. Carbomer 0.4%; 14. GT-730 (PEG-240 / HDI Copolymer Bis-Decyl Tetraeth-20 Ether, Butylene Glycol) 1.8%; 15 , Sodium hyaluronate 0.1%; 16. Polyglutamic acid 0.2%;
[0077] Phase C: 17. Triethanolamine 0.3%;
[0078] Phase D (Performance Composition, (Dimethicone / Vinyl Dimethicone Crosspolymer, Water, C12-14 Pareth-12), and Anti-Sensitivity ...
Embodiment 3
[0090] The present embodiment provides a kind of eye cream for staying up late, comprising the following components by weight percentage:
[0091] Phase A (oil phase):
[0092] 1. Polyglycerol-10 stearate 0.6%; 2. Capryl polymethicone 2.0%; 3. Polydimethylsiloxane 2.0%; 4. Polymethylsilsesquioxane 1.0% 5. Babassu seed oil 1.0%; 6. Phytosterol oleate 0.5%; 7. Tocopheryl acetate 1.0%;
[0093] Phase B (including part of the water phase):
[0094] 8. Ultrapure water 43.75%; 9. Glycerin 8.0%; 10. 1,3-Propanediol 3.0%; 11. Hydrogenated lecithin 0.5%; 12. EMT-15 (hydroxyethyl acrylate / acryloyl dimethyl taurine Sodium Acetate Copolymer) 0.5%; 13. Carbomer 0.4%; 14. GT-730 (PEG-240 / HDI Copolymer Bis-Decyl Tetradeceth-20 Ether, Butylene Glycol) 1.5%; 15 , Sodium hyaluronate 0.1%; 16. Polyglutamic acid 0.3%;
[0095] Phase C: 17. Triethanolamine 0.3%;
[0096] Phase D (Performance Composition, (Dimethicone / Vinyl Dimethicone Crosspolymer, Water, C12-14 Pareth-12), and Anti-Sensitivi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com